Peter K. Honig
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 4
- Co-authors
- Louis R. CantilenaKaveh ZamaniRaymond L. WoosleyDale P. ConnerDale C. WorthamAllen BrinkerCarol PamerJerry L. Phillips
- Journals
- Clinical Pharmacology & Therapeutics (13 papers)The Journal of Clinical Pharmacology (4 papers)JAMA (3 papers)Nature Reviews Drug Discovery (3 papers)Pharmacoepidemiology and Drug Safety (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Peter K. Honig
39 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Pharmacology 621
- Geriatrics and Gerontology 264
- Emergency Medical Services 236
- Toxicology 89
- Medical Laboratory Technology 39
Countries citing papers authored by Peter K. Honig
This map shows the geographic impact of Peter K. Honig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Honig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Honig more than expected).
Fields of papers citing papers by Peter K. Honig
This network shows the impact of papers produced by Peter K. Honig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Honig. The network helps show where Peter K. Honig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter K. Honig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 34 | |
| 2 | Mission Possible: How FDA Can Move at the Speed of Science | 2015 | 3 |
| 3 | 2010 | 3 | |
| 4 | 2003 | 20 | |
| 5 | 2003 | 18 | |
| 6 | 2003 | 35 | |
| 7 | 2001 | 16 | |
| 8 | 1998 | 20 | |
| 9 | 1997 | 4 | |
| 10 | 1997 | 26 | |
| 11 | 1996 | 143 | |
| 12 | 1996 | 48 | |
| 13 | 1995 | 16 | |
| 14 | 1995 | 34 | |
| 15 | 1994 | 4 | |
| 16 | 1993 | 22 | |
| 17 | 1993 | 76 | |
| 18 | Terfenadine-Ketoconazole Interaction Hit paper breakdown → | 1993 | 521 |
| 19 | 1993 | 88 | |
| 20 | 1992 | 284 |
About Peter K. Honig
Peter K. Honig is a scholar working on Toxicology, Geriatrics and Gerontology, Statistics and Probability, Pharmacology and Analytical Chemistry, having authored 39 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (6 papers), Statistical Methods in Clinical Trials (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Pharmacology (621 citations), Geriatrics and Gerontology (264 citations), Emergency Medical Services (236 citations), Toxicology (89 citations) and Medical Laboratory Technology (39 citations). Peter K. Honig has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Louis R. Cantilena, Kaveh Zamani, Raymond L. Woosley, Dale P. Conner, Dale C. Wortham, Allen Brinker, Carol Pamer, Jerry L. Phillips, Robert Benton and Douglas Shaffer. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, JAMA, Nature Reviews Drug Discovery and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.